Unternehmen wird geladen
Just reported
Q3 2026 results
From Iradimed's results release of 30. Oktober 2026; its quarterly report has since been filed.
Revenue
Actual
24,2M $
+14 % y/y
+18 % q/qGuided
—
No guide given
EPS, GAAP
Actual
0,51 $
+19 % y/y
+24 % q/qGuided
—
No guide given
Operating income, GAAP
Actual
8,1M $
+19 % y/y
+27 % q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes Iradimed is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Devices
Graded A or B and worth $2B or more: A first, then the largest.
MDTMedtronic plc131,6B $A+
SYKStryker Corp.117,9B $A+
EWEdwards Lifesciences Corporation61,6B $A+
GEHCGE Healthcare Technologies Inc.37,5B $A
GKOSGlaukos Corp14,5B $A
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21. Okt. 2026CBGraded C, now B
MCKMckesson Corporation4. Nov. 2026BAGraded B, now A
CVSCVS Health Corp4. Nov. 2026BAGraded B, now A- EWEdwards Lifesciences Corporation4. Nov. 2026BAGraded B, now A
- GEHCGE Healthcare Technologies Inc.28. Okt. 2026CAGraded C, now A
Womit das Unternehmen Geld verdient
- MRI-compatible IV infusion pump systems34 %
- MRI-compatible patient vital signs monitoring systems33 %
- Ferromagnetic detection systems3 %
- Disposable products22 %
- Extended maintenance agreements3 %
- Services and other5 %
Die Umsatzanteile sind Schätzungen für nine months ended September 30, 2026 und keine Zahlen aus einem eingereichten Bericht.
Konkurriert mit
- PHGInvivo Research, owned by Koninklijke PhilipsD
- Größe
- 29,2B $
- Marge
- 0,0 %
- GEHCGE HealthCare TechnologiesA
- Größe
- 37,5B $
- Marge
- 10,0 %
- Schiller AG
- B. Braun
- FSNUYFresenius Kabi, a division of Fresenius SE & Co. KGaA
- MIPM Mammendorfer Institut für Physik und Medizin
Was es verkauft5
MRidium 3870 MRI-compatible IV infusion pump system
A pump system designed to deliver medicines and fluids in the MRI room. It includes a non-magnetic pump, mobile stand, disposable tubing, and optional remote controls.
MRidium 3860+ MRI-compatible IV infusion pump system
An earlier pump system for delivering medicines and fluids during MRI procedures. IRadimed planned to stop new system sales during 2026 while continuing contracted warranty and technical support.
3880 MRI-compatible patient vital signs monitoring system
A portable monitor that tracks measures such as heart activity, blood oxygen, blood pressure, breathing, and temperature during MRI procedures and patient transport.
2 weitere anzeigen
3600 ferromagnetic detection system with remote alarm logging unit
Equipment that detects approaching ferromagnetic metal near an MRI room and gives staff a remote screen for viewing alarms and logging items.
MRidium disposable IV tubing sets
Single-use tubing sets that connect the infusion pump to a patient and are made for different types of fluid delivery.
Wer es kauft3
- Hospitals and acute care facilities in the United States, which buy directly from IRadimed.
- Hospitals and acute care facilities outside the United States, generally reached through independent distributors.
- Hospital groups and group purchasing organizations that negotiate prices and purchasing terms for member hospitals.
Worauf es steht, und was es umwerfen könnte
Wovon das Geschäft abhängt
- 1Sales depend substantially on a small number of product types, especially MRI-compatible infusion pumps and patient monitors.
- 2Some critical materials and components come from single suppliers; some components used by IRadimed or its suppliers are made in China or Taiwan.
- 3IRadimed manufactures and stores products at a single facility in Florida.
- 4International sales depend on independent distributors continuing to buy and sell IRadimed products.
Was schiefgehen könnte
- 1A disruption to sales of the infusion pumps, patient monitors, or other limited product range could materially affect the business; the company also planned to end new sales of the 3860+ pump system during 2026.
- 2A supplier interruption, trade restriction, or problem at the Florida facility could limit product manufacturing and delivery.
- 3Failure or delay in meeting medical-device regulatory requirements, obtaining clearances for new products, or maintaining required certifications could delay sales or prevent products from being sold in some markets.
Über Iradimed Corp.
IRadimed makes medical equipment that can operate in the powerful magnetic fields around MRI scanners. Its intravenous (IV) pumps deliver medicines and fluids during scans, while its monitors track patients’ vital signs; both are designed to move with patients between hospital departments and the scanner. It also sells equipment that detects ferromagnetic metal near MRI rooms, along with disposable tubing, maintenance agreements, and repair services.
- Hauptsitz
- Orlando, Florida
- Gegründet
- 1992
- Beschäftigte
- 166 (December 31, 2025, high)
- Notiert an
- Nasdaq Global Market
- Geschäftsjahresende
- December 31
Gebaut aus den eigenen Einreichungen von Iradimed Corp. bei der US-Börsenaufsicht Securities and Exchange Commission (SEC). Die Zahlen sind wie berichtet, die Historie je Aktie auf die heutige Aktienbasis umgerechnet. Dies beschreibt ein Unternehmen — es ist keine Anlageberatung und keine Kauf- oder Verkaufsempfehlung.
